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OBJECTIVES
Evaluate the influence of nested case-control design on results of genetic 
association studies.
Design 1: Selection by incidence density sampling
ØSample controls from the set of all participants at risk for disease at the time 
the case became affected.
• No prevalent cases
• Later cases can serve as controls for earlier cases
Design 2: Selection based on affection status at end of study follow up
• Prevalent & incident cases
• No one ever affected by end of study can serve as control (“case 
exclusion”)
FHS cohort
Ø A community-based, multigenerational, longitudinal study of cardiovascular 
disease and its risk factors, including diabetes. 
Ø Began in 1948 to investigate the causes of heart disease. 
Ø 6752 subjects = 765 pedigrees with 2 to 301 genotyped subjects: 
• 134 pedigrees with 2
• 123 with 3
• 98 with 4
• 85 with 5
• 177 with 6 to 10
• 72 with 11 to 15
• 30 with 16 to 20 and
• 46 with more than 20
Example
Ø T2D (Type 2 Diabetes) is metabolic disorder primarily characterized by insulin 
resistance, relative insulin deficiency, and hyperglycemia.
WHO definition:
• Fasting plasma glucose ≥ 7.0 mmol/l (126 mg/dl)
or
• OGGT +2hrs plasma glucose ≥ 11.1 mmol/l (200 mg/dl)
In FHS: 
• Original Cohort, casual blood sugar > 200 mg/dl or  treatment for diabetes. 
• Offspring and Gen3 Cohorts, fasting blood sugar > 125 mg/dl or on 
treatment. 
18 SNPs in Analysis 
Ø Analyzed SNP variants convincingly associated with T2D in recent studies
Ø For SNPs not available in our FHS data, we have used SNPs with a r2>0.8 
instead of them :
• HHEX; rs5015480 (r2=1 with rs1111875)
• TCF7L2; rs7901695 (r2=0.8 with rs7903146)
• KCNJ11; rs5215 (r2=0.89 with rs5219)
• CDC123; rs4747969 (r2=0.83 with rs12779790)
• WFS1; rs4689394 (r2=1 with rs10010131)
• THADA; rs13431070 (r2=1 with rs7578597)
18 SNPs in Analysis (2)
Cofounding factors
Ø BMI: Body Mass Index
We have matched cases and controls on BMI at enrollment, i.e. BMI at the first visit.
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Cofounding factors (2)
Ø Age
In our analysis, we have matched cases and controls on age at enrollment, 
i.e. age at the first visit.
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approach
Ø Incidence density sampling method in Longitudinal study:
Compare 1 case to 10 non-cases at time of event
Principle:
Time
Persons
Event
Approach (2)
Create a risk set for each case = Identify all members of the cohort at risk for the 
event at the time the case is diagnosed. Potential confounders could be added to 
definition of risk set (rs) (we used age,BMI and sex).
Criteria: Age  5years; BMI  2kg/m2
Cleaning data: 1976 individuals in our global sample, after removing duplicate = 719 individuals
Approach (3)
Case exclusion sampling method in Longitudinal study:
Compare 1 case to 10 non-cases at time of event
Principle:
Time
Persons
Last Known Status
Select matched controls for each case = Identify all members of the controls 
cohort matched with the case included in the cases cohort. Potential confounders 
could be added. (we used age, BMI and sex)
Approach (4)
Results: Incidence density
Ø All SNPs are in HWE for the 10 generated samples
Results: case exclusion
Ø All SNPs are in HWE for the 10 generated samples
Conclusion
